Fig. 8 | Scientific Reports

Fig. 8

From: Identification of clusters related to programmed cell death and potential prognostic biomarkers for immunotherapy response in endometrial cancer

Fig. 8

Therapeutic agent screening for high-RS patients. (A–B) Evaluation of cisplatin sensitivity to assess the reliability of the algorithmic methodology. (C–D) Analysis of correlations and differences in drug sensitivity for potential compounds screened from the CTRP and PRISM datasets. (E) Comparison of relative mRNA expression of seven hub genes in human endometrial epithelial cells (HEEC) and EC cell lines (Ishikawa, HEC-1 A, RL-95-2). (F) Immunohistochemistry (IHC) analysis showing FBN3 protein expression in EC tissues (n = 10) and normal endometrial tissues (n = 10); ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

Back to article page